MAUNA KEA TECHNOLOGIES (ALMKT.PA) Fundamental Analysis & Valuation

EPA:ALMKT • FR0010609263

Current stock price

0.191 EUR
0 (-0.21%)
Last:

This ALMKT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALMKT.PA Profitability Analysis

1.1 Basic Checks

  • ALMKT had negative earnings in the past year.
  • In the past year ALMKT has reported a negative cash flow from operations.
  • In the past 5 years ALMKT always reported negative net income.
  • In the past 5 years ALMKT always reported negative operating cash flow.
ALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of ALMKT (-82.18%) is worse than 91.38% of its industry peers.
Industry RankSector Rank
ROA -82.18%
ROE N/A
ROIC N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMKT.PA Yearly ROA, ROE, ROICALMKT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • ALMKT's Gross Margin of 31.67% is on the low side compared to the rest of the industry. ALMKT is outperformed by 79.31% of its industry peers.
  • In the last couple of years the Gross Margin of ALMKT has grown nicely.
  • The Profit Margin and Operating Margin are not available for ALMKT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
ALMKT.PA Yearly Profit, Operating, Gross MarginsALMKT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ALMKT.PA Health Analysis

2.1 Basic Checks

  • ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALMKT has more shares outstanding than it did 1 year ago.
  • ALMKT has more shares outstanding than it did 5 years ago.
  • ALMKT has a worse debt/assets ratio than last year.
ALMKT.PA Yearly Shares OutstandingALMKT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALMKT.PA Yearly Total Debt VS Total AssetsALMKT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • ALMKT has an Altman-Z score of -7.53. This is a bad value and indicates that ALMKT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ALMKT (-7.53) is worse than 91.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.53
ROIC/WACCN/A
WACC6.75%
ALMKT.PA Yearly LT Debt VS Equity VS FCFALMKT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.23 indicates that ALMKT may have some problems paying its short term obligations.
  • ALMKT's Current ratio of 0.23 is on the low side compared to the rest of the industry. ALMKT is outperformed by 91.38% of its industry peers.
  • A Quick Ratio of 0.12 indicates that ALMKT may have some problems paying its short term obligations.
  • ALMKT has a Quick ratio of 0.12. This is amonst the worse of the industry: ALMKT underperforms 94.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.12
ALMKT.PA Yearly Current Assets VS Current LiabilitesALMKT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ALMKT.PA Growth Analysis

3.1 Past

  • The earnings per share for ALMKT have decreased strongly by -114.81% in the last year.
  • The Revenue for ALMKT has decreased by -26.96% in the past year. This is quite bad
  • ALMKT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.60% yearly.
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%

3.2 Future

  • ALMKT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.86% yearly.
  • The Revenue is expected to grow by 19.29% on average over the next years. This is quite good.
EPS Next Y50%
EPS Next 2Y61.25%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y19.76%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALMKT.PA Yearly Revenue VS EstimatesALMKT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ALMKT.PA Yearly EPS VS EstimatesALMKT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALMKT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMKT. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 3.09 indicates a rather cheap valuation of ALMKT.
  • Based on the Price/Forward Earnings ratio, ALMKT is valued cheaply inside the industry as 98.28% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ALMKT to the average of the S&P500 Index (21.99), we can say ALMKT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.09
ALMKT.PA Price Earnings VS Forward Price EarningsALMKT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMKT.PA Per share dataALMKT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALMKT's earnings are expected to grow with 23.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.25%
EPS Next 3Y23.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALMKT.PA Dividend Analysis

5.1 Amount

  • ALMKT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMKT.PA Fundamentals: All Metrics, Ratios and Statistics

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (4/27/2026, 7:00:00 PM)

0.191

0 (-0.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-15
Earnings (Next)07-21
Inst Owners5.63%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap36.69M
Revenue(TTM)7.66M
Net Income(TTM)-10.40M
Analysts86
Price Target0.36 (88.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-30%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.09
P/S 4.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)0.06
Fwd EY32.36%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.04
BVpS-0.15
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -82.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.67%
FCFM N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.33%
Cap/Sales 3.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.12
Altman-Z -7.53
F-Score3
WACC6.75%
ROIC/WACCN/A
Cap/Depr(3y)16.65%
Cap/Depr(5y)36.4%
Cap/Sales(3y)2.78%
Cap/Sales(5y)7.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
EPS Next Y50%
EPS Next 2Y61.25%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
Revenue Next Year0%
Revenue Next 2Y19.76%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y-594.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.14%
EBIT Next 3Y23.7%
EBIT Next 5YN/A
FCF growth 1Y-3920%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2465%
OCF growth 3YN/A
OCF growth 5YN/A

MAUNA KEA TECHNOLOGIES / ALMKT.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA.


What is the valuation status of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MAUNA KEA TECHNOLOGIES (ALMKT.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for MAUNA KEA TECHNOLOGIES?

MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ALMKT stock?

The Earnings per Share (EPS) of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is expected to grow by 50% in the next year.